In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
CTET 2024: Another chance to register for CTET July, the deadline extended till this day; apply soon
CTET July 2024: The Central Board of Secondary Education has extended the last date for submissio
The audience's desire to see Salman Khan and Shah Rukh Khan together on screen was fulfilled by t
After the films have landed in theatres, now the audience eagerly waits for their arrival on OTT.
Microsoft has decided to buy 'CandyCrush' video game maker Activision Blizzard for $ 68.7 billion
Comment on Prophet: 1 crore reward for cutting off Nupur Sharma's tongue, Bhim Army announced
The issue of objectionable remarks by former BJP spokesperson Nupur Sharma on Prophet Mohammad is
Jimmy Donaldson, popularly known as MrBeast, has become the YouTuber with the most subscribers, l
Like last year, this year also the Odisha government has issued a ban on the world-famous Mahapra
Haryana: A tanker filled with oxygen to go from Panipat refinery to Sirsa, disappeared
There is a shortage of oxygen all over the country, now its theft is also happening. A medical-gr
Tesla CEO Elon Musk has become the new owner of the social networking site Twitter. After the acq
Bully bai app: Mischief of Uttarakhand woman and engineer, both arrested
Mumbai Police has arrested a woman, the main accused in the 'Bully Bai' case. The woman is accuse
